Krina T, Zondervan DPCM, Stacey A, Missmer SD. Endometriosis. New Engl J Med. 2020;382(13):1244–56.
Agostinis C, Balduit A, Mangogna A, et al. Immunological basis of the endometriosis: the complement system as a potential therapeutic target. Front Immunol. 2021;11:599117.
Article PubMed PubMed Central Google Scholar
Bjedov S, Lvodylnxã LX, RãnrHãlq DD, et al. Endometriosis, pain and mental health. Psychiatria Danubina. 2021;33(Suppl 4):632–6.
Lagana AS, Garzon S, Gotte M, et al. The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights. Int J Mol Sci. 2019;20(22):5615.
Article CAS PubMed PubMed Central Google Scholar
Sampson JA. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol. 1927;3(2):93–110.
CAS PubMed PubMed Central Google Scholar
Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20(2):69–84.
Article CAS PubMed Google Scholar
Das V, Bhattacharya S, Chikkaputtaiah C, et al. The basics of epithelial-mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective. J Cell Physiol. 2019;234(9):14535–55.
Article CAS PubMed Google Scholar
Jolly MK, Ware KE, Gilja S, et al. EMT and MET: necessary or permissive for metastasis?. Mol Oncol. 2017;11(7):755–69.
Article PubMed PubMed Central Google Scholar
Matsuzaki S, Darcha C. Epithelial to mesenchymal transition-like and mesenchymal to epithelial transition-like processes might be involved in the pathogenesis of pelvic endometriosis. Hum Reprod. 2012;27(3):712–21.
Article CAS PubMed Google Scholar
Xiong W, Zhang L, Liu H, et al. E(2) -mediated EMT by activation of beta-catenin/Snail signalling during the development of ovarian endometriosis. J Cell Mol Med. 2019;23(12):8035–45.
Article CAS PubMed PubMed Central Google Scholar
Chen M, Zhou Y, Xu H, et al. Bioinformatic analysis reveals the importance of epithelial-mesenchymal transition in the development of endometriosis. Sci Rep. 2020;10(1):8442.
Article CAS PubMed PubMed Central Google Scholar
Lessey BA, Young SL. Integrins and other cell adhesion molecules in endometrium and endometriosis. Semin Reprod Endocrinol. 1997;15(3):291–9.
Article CAS PubMed Google Scholar
Elangbam CS, Qualls CJ, Dahlgren RR. Cell adhesion molecules–update. Vet Pathol. 1997;34(1):61–73.
Article CAS PubMed Google Scholar
Witz CA. Cell adhesion molecules and endometriosis. Semin Reprod Med. 2003;21(2):173–82.
Article CAS PubMed Google Scholar
Fogel AI, Akins MR, Krupp AJ, et al. SynCAMs organize synapses through heterophilic adhesion. J Neurosci. 2007;27(46):12516–30.
Article CAS PubMed PubMed Central Google Scholar
Robbins EM, Krupp AJ, Perez DAK, et al. SynCAM 1 adhesion dynamically regulates synapse number and impacts plasticity and learning. Neuron. 2010;68(5):894–906.
Article CAS PubMed PubMed Central Google Scholar
Li H, Gao J, Zhang S. Functional and Clinical Characteristics of Cell Adhesion Molecule CADM1 in Cancer. Front Cell Dev Biol. 2021;9:714298.
Article PubMed PubMed Central Google Scholar
Wu D, Lei Y, Liu Q, et al. Characterization and clinical significance of the CADM1/HER2/STAT3 axis in serous ovarian tumors. Medicine (Baltimore). 2021;100(8):e23777.
Article CAS PubMed Google Scholar
Del Pino M, Sierra A, Marimon L, et al. CADM1, MAL, and miR124 promoter methylation as biomarkers of transforming cervical intrapithelial lesions. Int J Mol Sci. 2019;20(9):2262–2262.
Article PubMed PubMed Central Google Scholar
Fortune JE, Wissler RN, Vincent SE. Prolactin modulates steroidogenesis by rat granulosa cells: II. effects on estradiol. Biol Reprod. 1986;35(1):92–9.
Article CAS PubMed Google Scholar
Zhang G, Zhong L, Luo H, et al. MicroRNA-155-3p promotes breast cancer progression through down-regulating CADM1. Onco Targets Ther. 2019;12:7993–8002.
Article CAS PubMed PubMed Central Google Scholar
Shi XY, Sun YZ, Li M, et al. LncRNA CADM1-AS1 serves as a new prognostic biomarker for gastric cancer. Eur Rev Med Pharmacol Sci. 2019;23(3 Suppl):232–8.
Kim KJ, Kim JY, Hong SM, et al. Loss of CADM4 expression is associated with poor prognosis in small intestinal adenocarcinomas. APMIS. 2017;125(5):437–43.
Article CAS PubMed Google Scholar
Saito M, Goto A, Abe N, et al. Decreased expression of CADM1 and CADM4 are associated with advanced stage breast cancer. Oncol Lett. 2018;15(2):2401–6.
Bang S, Jee S, Son H, et al. Decreased expression of cell adhesion molecule 4 in gastric adenocarcinoma and its prognostic implications. Diagnostics. 2022;12(4):941.
Biederer T. Bioinformatic characterization of the SynCAM family of immunoglobulin-like domain-containing adhesion molecules. Genomics. 2006;87(1):139–50.
Article CAS PubMed Google Scholar
Budhu A, Forgues M, Ye QH, et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell. 2006;10(2):99–111.
Article CAS PubMed Google Scholar
Yang S, Yan HL, Tao QF, et al. Low CADM2 expression predicts high recurrence risk of hepatocellular carcinoma patients after hepatectomy. J Cancer Res Clin Oncol. 2014;140(1):109–16.
Article CAS PubMed Google Scholar
Li D, Zhang Y, Zhang H, et al. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma. J Exp Clin Cancer Res. 2018;37(1):46.
Article PubMed PubMed Central Google Scholar
Lu C, Qiao P, Fu R, et al. Phosphorylation of PFKFB4 by PIM2 promotes anaerobic glycolysis and cell proliferation in endometriosis. Cell Death Dis. 2022;13(9):790.
Article CAS PubMed PubMed Central Google Scholar
Lu C, Ren C, Yang T, Sun Y, Qiao P, Wang D, Lv S, Yu Z. A noncanonical role of fructose-1, 6-bisphosphatase 1 Is essential for inhibition of notch1 in breast cancer. Mol Cancer Res. 2020;18(5):787–96.
Article CAS PubMed Google Scholar
Gaetje R, Kotzian S, Herrmann G, et al. Nonmalignant epithelial cells, potentially invasive in human endometriosis, lack the tumor suppressor molecule E-cadherin. Am J Pathol. 1997;150(2):461–7.
CAS PubMed PubMed Central Google Scholar
Chang G, Xu S, Dhir R, et al. Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer. Clin Cancer Res. 2010;16(22):5390–401.
Article CAS PubMed PubMed Central Google Scholar
Li X, Chen D, Li M, et al. The CADM2/Akt pathway is involved in the inhibitory effect of miR-21-5p downregulation on proliferation and apoptosis in esophageal squamous cell carcinoma cells. Chem Biol Interact. 2018;288:76–82.
Article CAS PubMed Google Scholar
Zhu ZQ, Hu HF, Zheng XY, et al. Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms. Zhonghua Zhong Liu Za Zhi. 2020;42(8):635–43.
Liu N, Yang C, Bai W, et al. CADM2 inhibits human glioma proliferation, migration and invasion. Oncol Rep. 2019;41(4):2273–80.
Huang YX, Nie XG, Li GD, et al. Downregulation of microRNA-182 inhibits cell viability, invasion and angiogenesis in retinoblastoma through inhibition of the PI3K/AKT pathway and CADM2 upregulation. Int J Oncol. 2018;53(6):2615–26.
Dai L, Zhao J, Yin J, et al. Cell adhesion molecule 2 (CADM2) promotes brain metastasis by inducing epithelial-mesenchymal transition (EMT) in human non-small cell lung cancer. Ann Transl Med. 2020;8(7):465.
留言 (0)